Clinical Trial Update: Safety, Tolerability, and PK/PD of CIGB-814 in Chinese Health Participants [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating safety, tolerability, and PK/PD of CIGB-814 in Chinese participants with rheumatoid arthritis; the study is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CIGB-814

Snippet

Sponsor: Yi Fang | Conditions: Rheumatoid Arthritis (RA) | Phase 1 | Status: RECRUITING